 | • レポートコード：QFJ1-4804 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、軟骨再生医療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（セルベース、非セルベース）、用途別市場規模（硝子軟骨修復＆再生、弾性軟骨修復＆再生、肋軟骨修復＆再生）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・軟骨再生医療の市場動向 ・企業の競争状況、市場シェア ・軟骨再生医療の種類別市場規模と予測2016-2027（セルベース、非セルベース） ・軟骨再生医療の用途別市場規模と予測2016-2027（硝子軟骨修復＆再生、弾性軟骨修復＆再生、肋軟骨修復＆再生） ・軟骨再生医療の北米市場規模2016-2027（アメリカ、カナダ） ・軟骨再生医療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・軟骨再生医療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・軟骨再生医療の中南米市場規模2016-2027（メキシコ、ブラジル） ・軟骨再生医療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（B. Braun Melsungen AG、Zimmer Biomet Holdings Inc.、Vericel Corporation、Stryker Corporation、Smith & Nephew plc、Arthrex Inc.、CONMED Corporation、Collagen Solutions PLC、BioTissue Technologies、CellGenix） ・結論 |
Market Analysis and Insights: Global Regenerative Medicine for Cartilage Market
The global Regenerative Medicine for Cartilage market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Regenerative Medicine for Cartilage market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Regenerative Medicine for Cartilage market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Regenerative Medicine for Cartilage market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Regenerative Medicine for Cartilage market.
Global Regenerative Medicine for Cartilage Scope and Market Size
Regenerative Medicine for Cartilage market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Regenerative Medicine for Cartilage market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Cell-based
Non-cell-based
Segment by Application
Hyaline Cartilage Repair and Regeneration
Elastic Cartilage Repair and Regeneration
Ribrous Cartilage Repair and Regeneration.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
B. Braun Melsungen AG
Zimmer Biomet Holdings Inc.
Vericel Corporation
Stryker Corporation
Smith & Nephew plc
Arthrex Inc.
CONMED Corporation
Collagen Solutions PLC
BioTissue Technologies
CellGenix
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Regenerative Medicine for Cartilage Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cell-based
1.2.3 Non-cell-based
1.3 Market by Application
1.3.1 Global Regenerative Medicine for Cartilage Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hyaline Cartilage Repair and Regeneration
1.3.3 Elastic Cartilage Repair and Regeneration
1.3.4 Ribrous Cartilage Repair and Regeneration.
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Regenerative Medicine for Cartilage Market Perspective (2016-2027)
2.2 Regenerative Medicine for Cartilage Growth Trends by Regions
2.2.1 Regenerative Medicine for Cartilage Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Regenerative Medicine for Cartilage Historic Market Share by Regions (2016-2021)
2.2.3 Regenerative Medicine for Cartilage Forecasted Market Size by Regions (2022-2027)
2.3 Regenerative Medicine for Cartilage Industry Dynamic
2.3.1 Regenerative Medicine for Cartilage Market Trends
2.3.2 Regenerative Medicine for Cartilage Market Drivers
2.3.3 Regenerative Medicine for Cartilage Market Challenges
2.3.4 Regenerative Medicine for Cartilage Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Regenerative Medicine for Cartilage Players by Revenue
3.1.1 Global Top Regenerative Medicine for Cartilage Players by Revenue (2016-2021)
3.1.2 Global Regenerative Medicine for Cartilage Revenue Market Share by Players (2016-2021)
3.2 Global Regenerative Medicine for Cartilage Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Regenerative Medicine for Cartilage Revenue
3.4 Global Regenerative Medicine for Cartilage Market Concentration Ratio
3.4.1 Global Regenerative Medicine for Cartilage Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Regenerative Medicine for Cartilage Revenue in 2020
3.5 Regenerative Medicine for Cartilage Key Players Head office and Area Served
3.6 Key Players Regenerative Medicine for Cartilage Product Solution and Service
3.7 Date of Enter into Regenerative Medicine for Cartilage Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Regenerative Medicine for Cartilage Breakdown Data by Type
4.1 Global Regenerative Medicine for Cartilage Historic Market Size by Type (2016-2021)
4.2 Global Regenerative Medicine for Cartilage Forecasted Market Size by Type (2022-2027)
5 Regenerative Medicine for Cartilage Breakdown Data by Application
5.1 Global Regenerative Medicine for Cartilage Historic Market Size by Application (2016-2021)
5.2 Global Regenerative Medicine for Cartilage Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Regenerative Medicine for Cartilage Market Size (2016-2027)
6.2 North America Regenerative Medicine for Cartilage Market Size by Type
6.2.1 North America Regenerative Medicine for Cartilage Market Size by Type (2016-2021)
6.2.2 North America Regenerative Medicine for Cartilage Market Size by Type (2022-2027)
6.2.3 North America Regenerative Medicine for Cartilage Market Size by Type (2016-2027)
6.3 North America Regenerative Medicine for Cartilage Market Size by Application
6.3.1 North America Regenerative Medicine for Cartilage Market Size by Application (2016-2021)
6.3.2 North America Regenerative Medicine for Cartilage Market Size by Application (2022-2027)
6.3.3 North America Regenerative Medicine for Cartilage Market Size by Application (2016-2027)
6.4 North America Regenerative Medicine for Cartilage Market Size by Country
6.4.1 North America Regenerative Medicine for Cartilage Market Size by Country (2016-2021)
6.4.2 North America Regenerative Medicine for Cartilage Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Regenerative Medicine for Cartilage Market Size (2016-2027)
7.2 Europe Regenerative Medicine for Cartilage Market Size by Type
7.2.1 Europe Regenerative Medicine for Cartilage Market Size by Type (2016-2021)
7.2.2 Europe Regenerative Medicine for Cartilage Market Size by Type (2022-2027)
7.2.3 Europe Regenerative Medicine for Cartilage Market Size by Type (2016-2027)
7.3 Europe Regenerative Medicine for Cartilage Market Size by Application
7.3.1 Europe Regenerative Medicine for Cartilage Market Size by Application (2016-2021)
7.3.2 Europe Regenerative Medicine for Cartilage Market Size by Application (2022-2027)
7.3.3 Europe Regenerative Medicine for Cartilage Market Size by Application (2016-2027)
7.4 Europe Regenerative Medicine for Cartilage Market Size by Country
7.4.1 Europe Regenerative Medicine for Cartilage Market Size by Country (2016-2021)
7.4.2 Europe Regenerative Medicine for Cartilage Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Regenerative Medicine for Cartilage Market Size (2016-2027)
8.2 Asia-Pacific Regenerative Medicine for Cartilage Market Size by Type
8.2.1 Asia-Pacific Regenerative Medicine for Cartilage Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Regenerative Medicine for Cartilage Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Regenerative Medicine for Cartilage Market Size by Type (2016-2027)
8.3 Asia-Pacific Regenerative Medicine for Cartilage Market Size by Application
8.3.1 Asia-Pacific Regenerative Medicine for Cartilage Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Regenerative Medicine for Cartilage Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Regenerative Medicine for Cartilage Market Size by Application (2016-2027)
8.4 Asia-Pacific Regenerative Medicine for Cartilage Market Size by Region
8.4.1 Asia-Pacific Regenerative Medicine for Cartilage Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Regenerative Medicine for Cartilage Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Regenerative Medicine for Cartilage Market Size (2016-2027)
9.2 Latin America Regenerative Medicine for Cartilage Market Size by Type
9.2.1 Latin America Regenerative Medicine for Cartilage Market Size by Type (2016-2021)
9.2.2 Latin America Regenerative Medicine for Cartilage Market Size by Type (2022-2027)
9.2.3 Latin America Regenerative Medicine for Cartilage Market Size by Type (2016-2027)
9.3 Latin America Regenerative Medicine for Cartilage Market Size by Application
9.3.1 Latin America Regenerative Medicine for Cartilage Market Size by Application (2016-2021)
9.3.2 Latin America Regenerative Medicine for Cartilage Market Size by Application (2022-2027)
9.3.3 Latin America Regenerative Medicine for Cartilage Market Size by Application (2016-2027)
9.4 Latin America Regenerative Medicine for Cartilage Market Size by Country
9.4.1 Latin America Regenerative Medicine for Cartilage Market Size by Country (2016-2021)
9.4.2 Latin America Regenerative Medicine for Cartilage Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Regenerative Medicine for Cartilage Market Size (2016-2027)
10.2 Middle East & Africa Regenerative Medicine for Cartilage Market Size by Type
10.2.1 Middle East & Africa Regenerative Medicine for Cartilage Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Regenerative Medicine for Cartilage Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Regenerative Medicine for Cartilage Market Size by Type (2016-2027)
10.3 Middle East & Africa Regenerative Medicine for Cartilage Market Size by Application
10.3.1 Middle East & Africa Regenerative Medicine for Cartilage Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Regenerative Medicine for Cartilage Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Regenerative Medicine for Cartilage Market Size by Application (2016-2027)
10.4 Middle East & Africa Regenerative Medicine for Cartilage Market Size by Country
10.4.1 Middle East & Africa Regenerative Medicine for Cartilage Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Regenerative Medicine for Cartilage Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 B. Braun Melsungen AG
11.1.1 B. Braun Melsungen AG Company Details
11.1.2 B. Braun Melsungen AG Business Overview
11.1.3 B. Braun Melsungen AG Regenerative Medicine for Cartilage Introduction
11.1.4 B. Braun Melsungen AG Revenue in Regenerative Medicine for Cartilage Business (2016-2021)
11.1.5 B. Braun Melsungen AG Recent Development
11.2 Zimmer Biomet Holdings Inc.
11.2.1 Zimmer Biomet Holdings Inc. Company Details
11.2.2 Zimmer Biomet Holdings Inc. Business Overview
11.2.3 Zimmer Biomet Holdings Inc. Regenerative Medicine for Cartilage Introduction
11.2.4 Zimmer Biomet Holdings Inc. Revenue in Regenerative Medicine for Cartilage Business (2016-2021)
11.2.5 Zimmer Biomet Holdings Inc. Recent Development
11.3 Vericel Corporation
11.3.1 Vericel Corporation Company Details
11.3.2 Vericel Corporation Business Overview
11.3.3 Vericel Corporation Regenerative Medicine for Cartilage Introduction
11.3.4 Vericel Corporation Revenue in Regenerative Medicine for Cartilage Business (2016-2021)
11.3.5 Vericel Corporation Recent Development
11.4 Stryker Corporation
11.4.1 Stryker Corporation Company Details
11.4.2 Stryker Corporation Business Overview
11.4.3 Stryker Corporation Regenerative Medicine for Cartilage Introduction
11.4.4 Stryker Corporation Revenue in Regenerative Medicine for Cartilage Business (2016-2021)
11.4.5 Stryker Corporation Recent Development
11.5 Smith & Nephew plc
11.5.1 Smith & Nephew plc Company Details
11.5.2 Smith & Nephew plc Business Overview
11.5.3 Smith & Nephew plc Regenerative Medicine for Cartilage Introduction
11.5.4 Smith & Nephew plc Revenue in Regenerative Medicine for Cartilage Business (2016-2021)
11.5.5 Smith & Nephew plc Recent Development
11.6 Arthrex Inc.
11.6.1 Arthrex Inc. Company Details
11.6.2 Arthrex Inc. Business Overview
11.6.3 Arthrex Inc. Regenerative Medicine for Cartilage Introduction
11.6.4 Arthrex Inc. Revenue in Regenerative Medicine for Cartilage Business (2016-2021)
11.6.5 Arthrex Inc. Recent Development
11.7 CONMED Corporation
11.7.1 CONMED Corporation Company Details
11.7.2 CONMED Corporation Business Overview
11.7.3 CONMED Corporation Regenerative Medicine for Cartilage Introduction
11.7.4 CONMED Corporation Revenue in Regenerative Medicine for Cartilage Business (2016-2021)
11.7.5 CONMED Corporation Recent Development
11.8 Collagen Solutions PLC
11.8.1 Collagen Solutions PLC Company Details
11.8.2 Collagen Solutions PLC Business Overview
11.8.3 Collagen Solutions PLC Regenerative Medicine for Cartilage Introduction
11.8.4 Collagen Solutions PLC Revenue in Regenerative Medicine for Cartilage Business (2016-2021)
11.8.5 Collagen Solutions PLC Recent Development
11.9 BioTissue Technologies
11.9.1 BioTissue Technologies Company Details
11.9.2 BioTissue Technologies Business Overview
11.9.3 BioTissue Technologies Regenerative Medicine for Cartilage Introduction
11.9.4 BioTissue Technologies Revenue in Regenerative Medicine for Cartilage Business (2016-2021)
11.9.5 BioTissue Technologies Recent Development
11.10 CellGenix
11.10.1 CellGenix Company Details
11.10.2 CellGenix Business Overview
11.10.3 CellGenix Regenerative Medicine for Cartilage Introduction
11.10.4 CellGenix Revenue in Regenerative Medicine for Cartilage Business (2016-2021)
11.10.5 CellGenix Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Regenerative Medicine for Cartilage Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cell-based
Table 3. Key Players of Non-cell-based
Table 4. Global Regenerative Medicine for Cartilage Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Regenerative Medicine for Cartilage Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Regenerative Medicine for Cartilage Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Regenerative Medicine for Cartilage Market Share by Regions (2016-2021)
Table 8. Global Regenerative Medicine for Cartilage Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Regenerative Medicine for Cartilage Market Share by Regions (2022-2027)
Table 10. Regenerative Medicine for Cartilage Market Trends
Table 11. Regenerative Medicine for Cartilage Market Drivers
Table 12. Regenerative Medicine for Cartilage Market Challenges
Table 13. Regenerative Medicine for Cartilage Market Restraints
Table 14. Global Regenerative Medicine for Cartilage Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Regenerative Medicine for Cartilage Market Share by Players (2016-2021)
Table 16. Global Top Regenerative Medicine for Cartilage Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Medicine for Cartilage as of 2020)
Table 17. Ranking of Global Top Regenerative Medicine for Cartilage Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Regenerative Medicine for Cartilage Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Regenerative Medicine for Cartilage Product Solution and Service
Table 21. Date of Enter into Regenerative Medicine for Cartilage Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Regenerative Medicine for Cartilage Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Regenerative Medicine for Cartilage Revenue Market Share by Type (2016-2021)
Table 25. Global Regenerative Medicine for Cartilage Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Regenerative Medicine for Cartilage Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Regenerative Medicine for Cartilage Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Regenerative Medicine for Cartilage Revenue Market Share by Application (2016-2021)
Table 29. Global Regenerative Medicine for Cartilage Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Regenerative Medicine for Cartilage Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Regenerative Medicine for Cartilage Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Regenerative Medicine for Cartilage Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Regenerative Medicine for Cartilage Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Regenerative Medicine for Cartilage Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Regenerative Medicine for Cartilage Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Regenerative Medicine for Cartilage Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Regenerative Medicine for Cartilage Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Regenerative Medicine for Cartilage Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Regenerative Medicine for Cartilage Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Regenerative Medicine for Cartilage Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Regenerative Medicine for Cartilage Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Regenerative Medicine for Cartilage Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Regenerative Medicine for Cartilage Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Regenerative Medicine for Cartilage Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Regenerative Medicine for Cartilage Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Regenerative Medicine for Cartilage Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Regenerative Medicine for Cartilage Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Regenerative Medicine for Cartilage Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Regenerative Medicine for Cartilage Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Regenerative Medicine for Cartilage Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Regenerative Medicine for Cartilage Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Regenerative Medicine for Cartilage Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Regenerative Medicine for Cartilage Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Regenerative Medicine for Cartilage Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Regenerative Medicine for Cartilage Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Regenerative Medicine for Cartilage Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Regenerative Medicine for Cartilage Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Regenerative Medicine for Cartilage Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Regenerative Medicine for Cartilage Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Regenerative Medicine for Cartilage Market Size by Country (2022-2027) & (US$ Million)
Table 61. B. Braun Melsungen AG Company Details
Table 62. B. Braun Melsungen AG Business Overview
Table 63. B. Braun Melsungen AG Regenerative Medicine for Cartilage Product
Table 64. B. Braun Melsungen AG Revenue in Regenerative Medicine for Cartilage Business (2016-2021) & (US$ Million)
Table 65. B. Braun Melsungen AG Recent Development
Table 66. Zimmer Biomet Holdings Inc. Company Details
Table 67. Zimmer Biomet Holdings Inc. Business Overview
Table 68. Zimmer Biomet Holdings Inc. Regenerative Medicine for Cartilage Product
Table 69. Zimmer Biomet Holdings Inc. Revenue in Regenerative Medicine for Cartilage Business (2016-2021) & (US$ Million)
Table 70. Zimmer Biomet Holdings Inc. Recent Development
Table 71. Vericel Corporation Company Details
Table 72. Vericel Corporation Business Overview
Table 73. Vericel Corporation Regenerative Medicine for Cartilage Product
Table 74. Vericel Corporation Revenue in Regenerative Medicine for Cartilage Business (2016-2021) & (US$ Million)
Table 75. Vericel Corporation Recent Development
Table 76. Stryker Corporation Company Details
Table 77. Stryker Corporation Business Overview
Table 78. Stryker Corporation Regenerative Medicine for Cartilage Product
Table 79. Stryker Corporation Revenue in Regenerative Medicine for Cartilage Business (2016-2021) & (US$ Million)
Table 80. Stryker Corporation Recent Development
Table 81. Smith & Nephew plc Company Details
Table 82. Smith & Nephew plc Business Overview
Table 83. Smith & Nephew plc Regenerative Medicine for Cartilage Product
Table 84. Smith & Nephew plc Revenue in Regenerative Medicine for Cartilage Business (2016-2021) & (US$ Million)
Table 85. Smith & Nephew plc Recent Development
Table 86. Arthrex Inc. Company Details
Table 87. Arthrex Inc. Business Overview
Table 88. Arthrex Inc. Regenerative Medicine for Cartilage Product
Table 89. Arthrex Inc. Revenue in Regenerative Medicine for Cartilage Business (2016-2021) & (US$ Million)
Table 90. Arthrex Inc. Recent Development
Table 91. CONMED Corporation Company Details
Table 92. CONMED Corporation Business Overview
Table 93. CONMED Corporation Regenerative Medicine for Cartilage Product
Table 94. CONMED Corporation Revenue in Regenerative Medicine for Cartilage Business (2016-2021) & (US$ Million)
Table 95. CONMED Corporation Recent Development
Table 96. Collagen Solutions PLC Company Details
Table 97. Collagen Solutions PLC Business Overview
Table 98. Collagen Solutions PLC Revenue in Regenerative Medicine for Cartilage Business (2016-2021) & (US$ Million)
Table 99. Collagen Solutions PLC Recent Development
Table 100. BioTissue Technologies Company Details
Table 101. BioTissue Technologies Business Overview
Table 102. BioTissue Technologies Regenerative Medicine for Cartilage Product
Table 103. BioTissue Technologies Revenue in Regenerative Medicine for Cartilage Business (2016-2021) & (US$ Million)
Table 104. BioTissue Technologies Recent Development
Table 105. CellGenix Company Details
Table 106. CellGenix Business Overview
Table 107. CellGenix Regenerative Medicine for Cartilage Product
Table 108. CellGenix Revenue in Regenerative Medicine for Cartilage Business (2016-2021) & (US$ Million)
Table 109. CellGenix Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Regenerative Medicine for Cartilage Market Share by Type: 2020 VS 2027
Figure 2. Cell-based Features
Figure 3. Non-cell-based Features
Figure 4. Global Regenerative Medicine for Cartilage Market Share by Application: 2020 VS 2027
Figure 5. Hyaline Cartilage Repair and Regeneration Case Studies
Figure 6. Elastic Cartilage Repair and Regeneration Case Studies
Figure 7. Ribrous Cartilage Repair and Regeneration. Case Studies
Figure 8. Regenerative Medicine for Cartilage Report Years Considered
Figure 9. Global Regenerative Medicine for Cartilage Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Regenerative Medicine for Cartilage Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Regenerative Medicine for Cartilage Market Share by Regions: 2020 VS 2027
Figure 12. Global Regenerative Medicine for Cartilage Market Share by Regions (2022-2027)
Figure 13. Global Regenerative Medicine for Cartilage Market Share by Players in 2020
Figure 14. Global Top Regenerative Medicine for Cartilage Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Medicine for Cartilage as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Regenerative Medicine for Cartilage Revenue in 2020
Figure 16. Global Regenerative Medicine for Cartilage Revenue Market Share by Type (2016-2021)
Figure 17. Global Regenerative Medicine for Cartilage Revenue Market Share by Type (2022-2027)
Figure 18. North America Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Regenerative Medicine for Cartilage Market Share by Type (2016-2027)
Figure 20. North America Regenerative Medicine for Cartilage Market Share by Application (2016-2027)
Figure 21. North America Regenerative Medicine for Cartilage Market Share by Country (2016-2027)
Figure 22. United States Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Regenerative Medicine for Cartilage Market Share by Type (2016-2027)
Figure 26. Europe Regenerative Medicine for Cartilage Market Share by Application (2016-2027)
Figure 27. Europe Regenerative Medicine for Cartilage Market Share by Country (2016-2027)
Figure 28. Germany Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Regenerative Medicine for Cartilage Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Regenerative Medicine for Cartilage Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Regenerative Medicine for Cartilage Market Share by Region (2016-2027)
Figure 38. China Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Regenerative Medicine for Cartilage Market Share by Type (2016-2027)
Figure 46. Latin America Regenerative Medicine for Cartilage Market Share by Application (2016-2027)
Figure 47. Latin America Regenerative Medicine for Cartilage Market Share by Country (2016-2027)
Figure 48. Mexico Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Regenerative Medicine for Cartilage Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Regenerative Medicine for Cartilage Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Regenerative Medicine for Cartilage Market Share by Country (2016-2027)
Figure 54. Turkey Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Regenerative Medicine for Cartilage Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. B. Braun Melsungen AG Revenue Growth Rate in Regenerative Medicine for Cartilage Business (2016-2021)
Figure 58. Zimmer Biomet Holdings Inc. Revenue Growth Rate in Regenerative Medicine for Cartilage Business (2016-2021)
Figure 59. Vericel Corporation Revenue Growth Rate in Regenerative Medicine for Cartilage Business (2016-2021)
Figure 60. Stryker Corporation Revenue Growth Rate in Regenerative Medicine for Cartilage Business (2016-2021)
Figure 61. Smith & Nephew plc Revenue Growth Rate in Regenerative Medicine for Cartilage Business (2016-2021)
Figure 62. Arthrex Inc. Revenue Growth Rate in Regenerative Medicine for Cartilage Business (2016-2021)
Figure 63. CONMED Corporation Revenue Growth Rate in Regenerative Medicine for Cartilage Business (2016-2021)
Figure 64. Collagen Solutions PLC Revenue Growth Rate in Regenerative Medicine for Cartilage Business (2016-2021)
Figure 65. BioTissue Technologies Revenue Growth Rate in Regenerative Medicine for Cartilage Business (2016-2021)
Figure 66. CellGenix Revenue Growth Rate in Regenerative Medicine for Cartilage Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の幹細胞軟骨再生市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Stem Cell Cartilage Regeneration Market The global Stem Cell Cartilage Regeneration market size is projected to reach US$ 356.5 million by 2027, from US$ 245.1 million in 2020, at a CAGR of 5.0% during 2021-2027. With industry-standard accuracy in analysis and hi…- 幹細胞軟骨再生のグローバル市場調査 2019年 The global Stem Cell Cartilage Regeneration market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Stem Cell Cartilage Regeneration volume and value at global level, regional level and company level. From …
- 幹細胞軟骨再生のグローバル市場調査 2019年 The global Stem Cell Cartilage Regeneration market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Stem Cell Cartilage Regeneration volume and value at global level, regional level and company level. From …
- 心筋血行再建・修復・再生製品・療法のグローバル市場調査 2019年 The global Myocardial Revascularization, Repair, and Regeneration Products and Therapies market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Myocardial Revascularization, Repair, and Regeneration Produc…
- 世界の組織再生エンジニアリング市場規模・現状・予測（2021年-2027年） Tissue Regeneration Engineering is a combination of cellular, engineering and materials methods and appropriate biochemical and physical and chemical factors to improve or replace biological tissue. Tissue Regeneration Engineering is to obtain a small amount of living tissue from the body, use speci…